Suivre
Jonathan Douxfils
Jonathan Douxfils
Head of Research Unit in Clinical Pharmacology at the University of Namur
Adresse e-mail validée de unamur.be - Page d'accueil
Titre
Citée par
Citée par
Année
Impact of dabigatran on a large panel of routine or specific coagulation assays
J Douxfils, F Mullier, S Robert, C Chatelain, B Chatelain, JM Dogné
Thrombosis and haemostasis 107 (05), 985-997, 2012
4692012
Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians
J Douxfils, W Ageno, CM Samama, S Lessire, H Ten Cate, P Verhamme, ...
Journal of Thrombosis and Haemostasis 16 (2), 209-219, 2018
3872018
International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of direct oral anticoagulants
RC Gosselin, DM Adcock, SM Bates, J Douxfils, EJ Favaloro, ...
Thrombosis and haemostasis 118 (03), 437-450, 2018
3802018
Assessment of the impact of rivaroxaban on coagulation assays: laboratory recommendations for the monitoring of rivaroxaban and review of the literature
J Douxfils, F Mullier, C Loosen, C Chatelain, B Chatelain, JM Dogné
Thrombosis research 130 (6), 956-966, 2012
2932012
Impact of apixaban on routine and specific coagulation assays: a practical laboratory guide
J Douxfils, C Chatelain, B Chatelain, JM Dogné, F Mullier
Thrombosis and haemostasis 110 (08), 283-294, 2013
2642013
Association between BCR-ABL tyrosine kinase inhibitors for chronic myeloid leukemia and cardiovascular events, major molecular response, and overall survival: a systematic …
J Douxfils, H Haguet, F Mullier, C Chatelain, C Graux, JM Dogne
JAMA oncology 2 (5), 625-632, 2016
2022016
Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban
J Douxfils, A Tamigniau, B Chatelain, C Chatelain, P Wallemacq, F Mullier, ...
Thromb Haemost 110 (3), 2013
1852013
2021 update of the International Council for Standardization in Haematology recommendations for laboratory measurement of direct oral anticoagulants
J Douxfils, DM Adcock, SM Bates, EJ Favaloro, I Gouin-Thibault, ...
Thrombosis and haemostasis 121 (08), 1008-1020, 2021
1702021
Antibody titres decline 3-month post-vaccination with BNT162b2
J Favresse, JL Bayart, F Mullier, M Elsen, C Eucher, SV Eeckhoudt, T Roy, ...
Emerg Microbes Infect. 10 (1), 1495-1498, 2021
1662021
Comparison of calibrated dilute thrombin time and aPTT tests with LC-MS/MS for the therapeutic monitoring of patients treated with dabigatran etexilate
J Douxfils, JM Dogné, F Mullier, B Chatelain, Y Rönquist-Nii, ...
Thromb Haemost 110 (3), 543-549, 2013
1442013
Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody
M Tré-Hardy, A Wilmet, I Beukinga, JM Dogné, J Douxfils, L Blairon
Clinical Chemistry and Laboratory Medicine (CCLM) 58 (8), 1357-1364, 2020
1262020
Dabigatran etexilate and risk of myocardial infarction, other cardiovascular events, major bleeding, and all‐cause mortality: a systematic review and meta‐analysis of …
J Douxfils, F Buckinx, F Mullier, V Minet, V Rabenda, JY Reginster, ...
Journal of the American Heart Association 3 (3), e000515, 2014
1252014
Perioperative management of patients on direct oral anticoagulants
V Dubois, AS Dincq, J Douxfils, B Ickx, CM Samama, JM Dogné, ...
Thrombosis Journal 15, 1-17, 2017
1242017
Waning of IgG, total and neutralizing antibodies 6 months post-vaccination with BNT162b2 in healthcare workers
JL Bayart, J Douxfils, C Gillot, C David, F Mullier, M Elsen, C Eucher, ...
Vaccines 9 (10), 1092, 2021
1232021
Clinical performance of the Elecsys electrochemiluminescent immunoassay for the detection of SARS-CoV-2 total antibodies
J Favresse, C Eucher, M Elsen, M Tré-Hardy, JM Dogné, J Douxfils
Clinical chemistry 66 (8), 1104-1106, 2020
1142020
Analytical and clinical validation of an ELISA for specific SARS‐CoV‐2 IgG, IgA, and IgM antibodies
M Tré‐Hardy, A Wilmet, I Beukinga, J Favresse, JM Dogné, J Douxfils, ...
Journal of medical virology 93 (2), 803-811, 2021
1132021
Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters
J Douxfils, C Klipping, I Duijkers, V Kinet, M Mawet, C Maillard, M Jost, ...
Contraception 102 (6), 396-402, 2020
1082020
Appropriateness of prescribing dabigatran etexilate and rivaroxaban in patients with nonvalvular atrial fibrillation: a prospective study
AS Larock, F Mullier, AL Sennesael, J Douxfils, B Devalet, C Chatelain, ...
Annals of Pharmacotherapy 48 (10), 1258-1268, 2014
1072014
Combined oral contraceptives and venous thromboembolism: review and perspective to mitigate the risk
L Morimont, H Haguet, JM Dogné, U Gaspard, J Douxfils
Frontiers in endocrinology 12, 769187, 2021
1032021
Laboratory assessment of direct oral anticoagulants
J Douxfils, RC Gosselin
Seminars in thrombosis and hemostasis 43 (03), 277-290, 2017
992017
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20